FDC has entered into definitive agreements for the acquisition of additional stake in Fair Deal Corporation pharmaceutical SA (PTY), South Africa (FDC SA) through secondary acquisition of 143,000 equity shares of FDC SA, having Face value of RAND 1 each, and representing 44% of the share capital of FOCSA from Pharma Q Holdings Pty (Pharma Q), one of the joint venture partner and settlement of outstanding loan of ZAR 6.5 million equivalent to approximately Rs 2,92,31,280 availed by FOCSA from Pharma Q.
The said transaction is subject to completion of various closing conditions. Upon completion of the transaction, the company would be holding 93% of the equity share capital of FOCSA, whereby FOC SA would become a subsidiary of the company.
FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: